Duality Advisers LP acquired a new stake in Colgate-Palmolive (NYSE:CL) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 38,724 shares of the company’s stock, valued at approximately $2,837,000.

Several other institutional investors and hedge funds have also made changes to their positions in the company. 1832 Asset Management L.P. grew its stake in shares of Colgate-Palmolive by 42.1% in the 4th quarter. 1832 Asset Management L.P. now owns 3,116 shares of the company’s stock valued at $214,000 after purchasing an additional 923 shares during the last quarter. Verus Capital Partners LLC purchased a new position in Colgate-Palmolive in the 4th quarter valued at $95,000. Macquarie Group Ltd. grew its position in Colgate-Palmolive by 82.4% in the 4th quarter. Macquarie Group Ltd. now owns 67,229 shares of the company’s stock valued at $4,628,000 after buying an additional 30,369 shares during the last quarter. Blackhawk Capital Partners LLC. purchased a new position in Colgate-Palmolive during the 1st quarter worth $933,000. Finally, Pensionfund Sabic lifted its stake in shares of Colgate-Palmolive by 5.0% in the 1st quarter. Pensionfund Sabic now owns 31,500 shares of the company’s stock worth $2,090,000 after acquiring an additional 1,500 shares during the period. Institutional investors and hedge funds own 77.13% of the company’s stock.

In other Colgate-Palmolive news, Director Michael B. Polk sold 3,115 shares of the business’s stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $68.08, for a total value of $212,069.20. Following the completion of the transaction, the director now directly owns 20,622 shares in the company, valued at approximately $1,403,945.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.78% of the stock is currently owned by insiders.

A number of research analysts have recently issued reports on the stock. Royal Bank of Canada reiterated a “buy” rating and set a $88.00 price target on shares of Colgate-Palmolive in a research note on Thursday. TheStreet downgraded Colgate-Palmolive from a “b” rating to a “c+” rating in a research note on Friday, May 1st. Morgan Stanley lowered Colgate-Palmolive from an “overweight” rating to an “equal weight” rating and set a $78.00 price objective on the stock. in a report on Wednesday, July 22nd. They noted that the move was a valuation call. SunTrust Banks boosted their target price on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “buy” rating in a research report on Friday, May 15th. Finally, Stifel Nicolaus upped their price target on shares of Colgate-Palmolive from $72.00 to $75.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company. Colgate-Palmolive has a consensus rating of “Hold” and an average price target of $74.92.

CL stock opened at $77.20 on Friday. The stock’s 50 day moving average price is $73.69 and its 200 day moving average price is $71.47. The firm has a market cap of $66.12 billion, a P/E ratio of 26.35, a PEG ratio of 4.76 and a beta of 0.60. The company has a debt-to-equity ratio of 21.51, a quick ratio of 0.66 and a current ratio of 0.96. Colgate-Palmolive has a 1 year low of $58.49 and a 1 year high of $77.46.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 31st. The company reported $0.74 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.05. Colgate-Palmolive had a return on equity of 942.99% and a net margin of 15.86%. The business had revenue of $3.90 billion for the quarter, compared to analyst estimates of $3.78 billion. During the same quarter last year, the company earned $0.72 earnings per share. The business’s revenue for the quarter was up .8% compared to the same quarter last year. On average, research analysts predict that Colgate-Palmolive will post 2.9 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be given a dividend of $0.44 per share. The ex-dividend date is Friday, July 17th. This represents a $1.76 dividend on an annualized basis and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 62.19%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Recommended Story: What is net income?

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.